India recorded 44983152 Coronavirus Cases since the epidemic began, according to the World Health Organization (WHO). In addition, India reported 531794 Coronavirus Deaths. This dataset includes a chart with historical data for India Coronavirus Cases.

India reported almost 45 million cases of the coronavirus (COVID-19) as of October 20, 2023, with more than 44 million recoveries and about 532 thousand fatalities. The number of cases in the country had a decreasing trend in the past months.

Burden on the healthcare system

With the world's second largest population in addition to an even worse second wave of the coronavirus pandemic seems to be crushing an already inadequate healthcare system. Despite vast numbers being vaccinated, a new variant seemed to be affecting younger age groups this time around. The lack of ICU beds, black market sales of oxygen cylinders and drugs needed to treat COVID-19, as well as overworked crematoriums resorting to mass burials added to the woes of the country. Foreign aid was promised from various countries including the United States, France, Germany and the United Kingdom. Additionally, funding from the central government was expected to boost vaccine production.

Situation overview
Even though days in April 2021 saw record-breaking numbers compared to any other country worldwide, a nation-wide lockdown has not been implemented. The largest religious gathering - the Kumbh Mela, sacred to the Hindus, along with election rallies in certain states continue to be held. Some states and union territories including Maharashtra, Delhi, and Karnataka had issued curfews and lockdowns to try to curb the spread of infections.

India reported over 44 million confirmed cases of the coronavirus (COVID-19) as of October 20, 2023. The number of people infected with the virus was declining across the south Asian country.

What is the coronavirus?

COVID-19 is part of a large family of coronaviruses (CoV) that are transmitted from animals to people. The name COVID-19 is derived from the words corona, virus, and disease, while the number 19 represents the year that it emerged. Symptoms of COVID-19 resemble that of the common cold, with fever, coughing, and shortness of breath. However, serious infections can lead to pneumonia, multi-organ failure, severe acute respiratory syndrome, and even death, if appropriate medical help is not provided.

COVID-19 in India

India reported its first case of this coronavirus in late January 2020 in the southern state of Kerala. That led to a nation-wide lockdown between March and June that year to curb numbers from rising. After marginal success, the economy opened up leading to some recovery for the rest of 2020. In March 2021, however, the second wave hit the country causing record-breaking numbers of infections and deaths, crushing the healthcare system. The central government has been criticized for not taking action this time around, with "#ResignModi" trending on social media platforms in late April. The government's response was to block this line of content on the basis of fighting misinformation and reducing panic across the country.

Maharashtra confirmed over 8.1 million cases of the coronavirus (COVID-19) as of October 20, 2023, with over 148 thousand fatalities and over eight million recoveries. A state-wide lockdown was implemented in late April 2021 to attempt reducing infections and deaths.

This dataset provides values for CORONAVIRUS CASES reported in several countries. The data includes current values, previous releases, historical highs and record lows, release frequency, reported unit and currency.

Delhi confirmed almost two million cases of the coronavirus (COVID-19) as of October 20, 2023, with over 26 thousand fatalities and over two million recoveries. The Delhi government, led by Arvind Kejriwal and the Aam Aadmi Party implemented a night and weekend curfew to curb infection numbers in late April 2021. The capital region faced acute shortage of oxygen and ICU beds during this time period.

This dataset provides values for CORONAVIRUS DEATHS reported in several countries. The data includes current values, previous releases, historical highs and record lows, release frequency, reported unit and currency.

To create the dataset, the top 10 countries leading in the incidence of COVID-19 in the world were selected as of October 22, 2020 (on the eve of the second full of pandemics), which are presented in the Global 500 ranking for 2020: USA, India, Brazil, Russia, Spain, France and Mexico. For each of these countries, no more than 10 of the largest transnational corporations included in the Global 500 rating for 2020 and 2019 were selected separately. The arithmetic averages were calculated and the change (increase) in indicators such as profitability and profitability of enterprises, their ranking position (competitiveness), asset value and number of employees. The arithmetic mean values of these indicators for all countries of the sample were found, characterizing the situation in international entrepreneurship as a whole in the context of the COVID-19 crisis in 2020 on the eve of the second wave of the pandemic. The data is collected in a general Microsoft Excel table. Dataset is a unique database that combines COVID-19 statistics and entrepreneurship statistics. The dataset is flexible data that can be supplemented with data from other countries and newer statistics on the COVID-19 pandemic. Due to the fact that the data in the dataset are not ready-made numbers, but formulas, when adding and / or changing the values in the original table at the beginning of the dataset, most of the subsequent tables will be automatically recalculated and the graphs will be updated. This allows the dataset to be used not just as an array of data, but as an analytical tool for automating scientific research on the impact of the COVID-19 pandemic and crisis on international entrepreneurship. The dataset includes not only tabular data, but also charts that provide data visualization. The dataset contains not only actual, but also forecast data on morbidity and mortality from COVID-19 for the period of the second wave of the pandemic in 2020. The forecasts are presented in the form of a normal distribution of predicted values and the probability of their occurrence in practice. This allows for a broad scenario analysis of the impact of the COVID-19 pandemic and crisis on international entrepreneurship, substituting various predicted morbidity and mortality rates in risk assessment tables and obtaining automatically calculated consequences (changes) on the characteristics of international entrepreneurship. It is also possible to substitute the actual values identified in the process and following the results of the second wave of the pandemic to check the reliability of pre-made forecasts and conduct a plan-fact analysis. The dataset contains not only the numerical values of the initial and predicted values of the set of studied indicators, but also their qualitative interpretation, reflecting the presence and level of risks of a pandemic and COVID-19 crisis for international entrepreneurship.

A majority of the coronavirus (COVID-19) cases in India affected people between ages 31 and 40 years as of October 18, 2021. Of these, the highest share of deaths during the measured time period was observed in people under the age of 50 years.

Based on a comparison of coronavirus deaths in 210 countries relative to their population, Peru had the most losses to COVID-19 up until July 13, 2022. As of the same date, the virus had infected over 557.8 million people worldwide, and the number of deaths had totaled more than 6.3 million. Note, however, that COVID-19 test rates can vary per country. Additionally, big differences show up between countries when combining the number of deaths against confirmed COVID-19 cases. The source seemingly does not differentiate between "the Wuhan strain" (2019-nCOV) of COVID-19, "the Kent mutation" (B.1.1.7) that appeared in the UK in late 2020, the 2021 Delta variant (B.1.617.2) from India or the Omicron variant (B.1.1.529) from South Africa.

The difficulties of death figures

This table aims to provide a complete picture on the topic, but it very much relies on data that has become more difficult to compare. As the coronavirus pandemic developed across the world, countries already used different methods to count fatalities, and they sometimes changed them during the course of the pandemic. On April 16, for example, the Chinese city of Wuhan added a 50 percent increase in their death figures to account for community deaths. These deaths occurred outside of hospitals and went unaccounted for so far. The state of New York did something similar two days before, revising their figures with 3,700 new deaths as they started to include “assumed” coronavirus victims. The United Kingdom started counting deaths in care homes and private households on April 29, adjusting their number with about 5,000 new deaths (which were corrected lowered again by the same amount on August 18). This makes an already difficult comparison even more difficult. Belgium, for example, counts suspected coronavirus deaths in their figures, whereas other countries have not done that (yet). This means two things. First, it could have a big impact on both current as well as future figures. On April 16 already, UK health experts stated that if their numbers were corrected for community deaths like in Wuhan, the UK number would change from 205 to “above 300”. This is exactly what happened two weeks later. Second, it is difficult to pinpoint exactly which countries already have “revised” numbers (like Belgium, Wuhan or New York) and which ones do not. One work-around could be to look at (freely accessible) timelines that track the reported daily increase of deaths in certain countries. Several of these are available on our platform, such as for Belgium, Italy and Sweden. A sudden large increase might be an indicator that the domestic sources changed their methodology.

Where are these numbers coming from?

The numbers shown here were collected by Johns Hopkins University, a source that manually checks the data with domestic health authorities. For the majority of countries, this is from national authorities. In some cases, like China, the United States, Canada or Australia, city reports or other various state authorities were consulted. In this statistic, these separately reported numbers were put together. For more information or other freely accessible content, please visit our dedicated Facts and Figures page.

ABSTRACT India is a tourist paradise. Given the country's rich cultural and historical history, diversity of environment, terrains, and natural beauty spots, tourism in India has significant potential. It is regarded as the most prominent and fastest-growing industry. Aside from being a substantial source of foreign exchange, tourism can generate many jobs. The tourism sector has become extremely unstable due to pandemics and infectious diseases. The COVID-19 froze the tourist industry worldwide, and countries worldwide, including India, proceeded to implement travel restrictions to prevent the virus from spreading. Finally, the tourism industry has suffered significant losses due to the severe epidemic of the new coronavirus. As the disease spread, officials in India imposed travel restrictions, social isolation, and a lockdown, effectively putting the country's tourism industry on hold. Travelers canceled their tours due to the virus concern, and agitation caused the tourist graph to plummet substantially. This study aims to determine the importance of the tourist sector in the Indian economy and assess the impact of COVID-19 on the Indian tourism industry. Keywords: Tourism, Foreign Exchange, COVID-19, Lockdown, Recession

Cite this Article: N. Shanmugasundaram and Velu Suresh Kumar, Impact of Covid -19 On Tourism Industry in India, International Journal of Management (IJM), 11 (3), 2020, pp. 960–966.

The impact of the coronavirus (COVID-19) pandemic had not only brought the global economy to a standstill but set the clock backwards on the developmental progress of several nations. While the rate of infection in India did not appear to be as high as in other countries, precautionary measures adopted dealt a severe blow to the country’s major industries - with the service sector bearing the largest brunt of estimated loss. Manufacturing made a swift recovery in the following months.

Impact of key industries

The loss incurred by enforcing a lockdown in the country was estimated at 26 billion U.S. dollars and a significant decline in GDP growth is also expected in the June quarter of 2020. With the imposition of restrictions on transportation worldwide, the trade sector also took a hit. Exports and imports saw a drastic decline in the country especially in the case of essential commodities such as petroleum, food crops, and coal, among others.

Effect on business in India

The growth rate of the automotive business in India was expected to be the most adversely affected followed by the power supply and IT sectors. Furthermore, many startups, small and medium enterprises in India expected to face issues of supply disruption and a decrease in demand. The effects of aid from the Narendra Modi-led government arguably did little to help in the face of a faltering economy.

The outbreak of the novel coronavirus in Wuhan, China, saw infection cases spread throughout the Asia-Pacific region. By April 13, 2024, India had faced over 45 million coronavirus cases. South Korea followed behind India as having had the second highest number of coronavirus cases in the Asia-Pacific region, with about 34.6 million cases. At the same time, Japan had almost 34 million cases. At the beginning of the outbreak, people in South Korea had been optimistic and predicted that the number of cases would start to stabilize. What is SARS CoV 2?Novel coronavirus, officially known as SARS CoV 2, is a disease which causes respiratory problems which can lead to difficulty breathing and pneumonia. The illness is similar to that of SARS which spread throughout China in 2003. After the outbreak of the coronavirus, various businesses and shops closed to prevent further spread of the disease. Impacts from flight cancellations and travel plans were felt across the Asia-Pacific region. Many people expressed feelings of anxiety as to how the virus would progress. Impact throughout Asia-PacificThe Coronavirus and its variants have affected the Asia-Pacific region in various ways. Out of all Asia-Pacific countries, India was highly affected by the pandemic and experienced more than 50 thousand deaths. However, the country also saw the highest number of recoveries within the APAC region, followed by South Korea and Japan.

Tamil Nadu confirmed about 3.6 million cases of the coronavirus (COVID-19) as of October 20, 2023, with over 38 thousand fatalities and over 3.5 million recoveries. India reported more than 45 million confirmed cumulative cases, including this state that same day.

India's quarterly GDP was estimated to grow by 8.4 percent in the second quarter of financial year 2022 compared to the same quarter in the previous fiscal year. While continuing to be a positive change, it was a significant reduction from the performance during the first quarter of fiscal year 2022 when GDP growth peaked by 20 percent.

Cost of the pandemic

As a result of the various lockdowns enforced since the onset of the coronavirus pandemic in 2020, the Indian economy has been reeling from a multibillion dollar setback. The GDP contribution as well as the employment rate among most major sectors, especially services and trade, had taken a hit. The agriculture sector was an exception, having experienced positive changes on both these fronts.

A slowly recovering economy

With the outbreak of the second wave of the pandemic in March 2021, the government redirected financial support to boost India’s vaccination campaign. As of February 2022, over a billion vaccine doses had been administered across the country. Furthermore, inflation within the country was expected to decline 2021 onwards. However, the stagnation of employment continued to remain a matter of concern with protests erupting across different states in 2022.

As of April 13, 2024, India had the highest number of confirmed deaths due to the outbreak of the novel coronavirus in the Asia-Pacific region, with over 533 thousand deaths. Comparatively, Indonesia, which had the second highest number of coronavirus deaths in the Asia-Pacific region, recorded approximately 162 thousand COVID-19 related deaths as of April 13, 2024. Contrastingly, Bhutan had reported 21 deaths due to COVID-19 as of April 13, 2024.

As of May 2022, the unemployment rate in India was recorded at nearly seven percent, a decrease from the previous month. While the unemployment rate had significantly declined over the course of 2021 since having peaked in April 2020, the breakout of new coronavirus variants coupled with recurring lockdowns resulted in a fluctuating trend of unemployment gripping the nation.

The trickle-down effect

Between February and April 2020, the share of households that experienced a fall in income shot up to nearly 46 percent. Inflation rates on goods and services including food products and fuel were expected to rise later this year. Social distancing resulted in job losses, specifically those within Indian society’s lower economic strata. Several households terminated domestic help services – essentially an unorganized monthly-paying job. Most Indians spent a large amount of time engaging in household chores themselves, making it the most widely practiced lockdown activity.

Aid from the Pradhan Mantri Garib Kalyan Yojana

The most devastating impact of the virus and the lockdown had been on the economically backward classes, with limited access to proper healthcare and other resources. As a result the government launched various programs and campaigns to help sustain such households. Under the Pradhan Mantri Garib Kalyan Yojana, 312 billion Indian rupees were accrued and provided to around 331 million beneficiaries that included women, construction workers, farmers, and senior citizens. More aid was announced in mid-May, to mainly support small businesses through the crisis.

As of May 2, 2023, the outbreak of the coronavirus disease (COVID-19) had been confirmed in almost every country in the world. The virus had infected over 687 million people worldwide, and the number of deaths had reached almost 6.87 million. The most severely affected countries include the U.S., India, and Brazil.

COVID-19: background information COVID-19 is a novel coronavirus that had not previously been identified in humans. The first case was detected in the Hubei province of China at the end of December 2019. The virus is highly transmissible and coughing and sneezing are the most common forms of transmission, which is similar to the outbreak of the SARS coronavirus that began in 2002 and was thought to have spread via cough and sneeze droplets expelled into the air by infected persons.

Naming the coronavirus disease Coronaviruses are a group of viruses that can be transmitted between animals and people, causing illnesses that may range from the common cold to more severe respiratory syndromes. In February 2020, the International Committee on Taxonomy of Viruses and the World Health Organization announced official names for both the virus and the disease it causes: SARS-CoV-2 and COVID-19, respectively. The name of the disease is derived from the words corona, virus, and disease, while the number 19 represents the year that it emerged.

The Indian state of Utter Pradesh reported the highest number of administered doses of the vaccine against the coronavirus (COVID-19) as of November 13, 2023. Furthermore, over 2.2 billion total vaccine doses were administered in India during the same time period.

Vaccination in India were administered since January 16, 2021, with the administration of vaccines to all health care workers in the first phase. In February, the vaccination program was expanded to cover front line workers. The second phase of the program began in March which included citizens above the age of 60 and subsequently, people above the age of 45 with comorbidities. India’s vaccination program currently includes two vaccines, namely, Oxford University – AstraZeneca’s Covidshield vaccine, manufactured by the Serum Institute of India and Bharat Biotech Covaxin. Russia's Sputnik V was expected to be added to the mix starting May 2021.

India administered over 2.2 billion vaccine doses for the coronavirus (COVID-19) as of October 20, 2022. The number of people infected with the virus was declining across the Asian country. With the onset of the second wave since late March 2021, the central government increased funding to boost vaccination production.